中华男科学杂志

参考文献

[1]Stein BS,Vangone S,Petersen RO,et al.Immunoperoxidase lo-calization of prostate-specific antigen[J].Am J Surg Pathol,1982,6(6):553-557.

[2]Ford TF,Butcher DN,Masters JR,et al.Immunocytochemicallocalizalion of prostate-specific antigen:specificity and applicationto clinical practice[J].Br J Urol,1985,57(1):50-55.

[3]Stege RH,Tribukait B,Carlstrom KA,et al.Tissue PSA fromfine-needle briopsies of prostatic carcinoma as related to serumP-SA clinical stage,cytolopgical grade,and DNA ploidy[J].Pros-tate,1999,38(3):183-188.

[4]Babaian RJ,Camps JL,Frangos DN,et al.Monoclonal prostate-specific antigen in untreated prostate cancer Relationship to clini-cal stage and grade[J].Cancer,1991,67(8):2200-2206.

[5]Lerner SE,Jacobsen SJ,Lilja H,et al.Free,complexed,and to-tal serum prostate-specific antigen concentration and their propor-tions in predicting stage,grade,and deoxyribo,nucleic acid ploidyin patients with adenocarcinoma of the prostate[J].Urology,1996,48(2):240-248.

[6]吴阶平主编.吴阶平泌尿外科学[M].济南:山东科学技术出版社,2004.1071,1076.

[7]Cohen RJ,Haffejee Z,Steele GS,et al.Advanced prostate canc-er with normal serum prostate-specific antigen values[J].ArchPathol Lab Med,1994,118(11):1123-1126.

[8]Sella A,Konichezky M,Flex D,et al.Low PSA metaslatic an-drogen-independent prostate cancer[J].Eur Urol,2000,38(3):250-254.

[9]Nishio R,Furaya Y,Nagakawa O,et al.Metastatic prostate cancerwith normal level of serum prostatic-specific antigen[J].Inter UrolNephrol,2003,35(2):189-192.